In late July, two of HCSC’s top leaders — CEO Paula Steiner and CFO Eric Feldstein — left the health insurer. A company spokesperson confirmed to Becker’s that HCSC would pursue a more aggressive approach as it competes in a dynamic marketplace. Sources close to HCSC also told Forbes the board was unhappy with Ms. Steiner’s long-term aspirations and strategies, despite the insurer’s billion-dollar growth under her leadership.
The sources told Forbes some leaders at HCSC are open to looking into large mergers. Competitors like Aetna and Cigna recently completed big mergers with CVS Health and Express Scripts, respectively, and UnitedHealth Group is expanding its physician footprint.
Still, Mr. Japsen writes “the regulatory and political hurdles could be too steep to pull off given the different ownership structures of [HCSC] and Anthem, but these aren’t ordinary times when it comes to deals within the health insurance industry.”
Read the full article here.
More articles on payers:
WellStar says Anthem Blue made false representations to customers
Kansas threatens termination of Aetna’s Medicaid contract
1 system joins North Carolina’s controversial reimbursement plan in 2nd sign-up period
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
